N/A
N=50
Maintaining Cognitive Health in Aging Veterans
Healthy People Programs
Bottom Line
View on ClinicalTrials.gov: NCT02023944 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
May 2019
Primary outcome: Primary: Knowledge of Memory Aging Questionnaire-Revised — 19.8; 19.5 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Memory and Aging Course (Other)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Nov 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Knowledge of Memory Aging Questionnaire-Revised |
19.8; 19.5 | — |
| SECONDARY Multifactorial Memory Questionnaire (MMQ) |
46.7; 38.7; 52.6; 50.5; 41.0; 36.5 | — |
Summary
Interventions aimed at disseminating information about cognitive aging and lifestyle factors that contribute to successful cognitive aging, in addition to providing broad cognitive skills training, may improve the psychological wellness and day-to-day functioning of the aging Veteran population. This 12-week course aims to teach older Veterans (age 50+) about brain aging, lifestyle factors that contribute to successful aging, and techniques that can boost cognition in daily life.
Eligibility Criteria
Inclusion Criteria
- Veterans age 50 and older who are concerned about their memory.
- Veterans age 50 and older who want to learn about memory processes.
Exclusion Criteria
Participants will be excluded if they display impairment on a cognitive screening measure, as determined using age and education corrected criteria with a minimum 90% specificity (using criteria: Schretlen, Testa, and Pearlson, 2010) as follows:
- Age Education MMSE Cut-off Specificity Sensitivity
- 51-55 / 26 or <
- 56-60 / 25 or <
- 61-65 / 25 or <
- 66-70 / 25 or <
- 71-75 / 23 or <
- 76-80 / 23 or <
- 86+ / 22 or <
- Or self or informant reported diagnosis of a brain disorder affecting cognition such as Alzheimer's disease, Mild Cognitive Impairment, Parkinson's disease, other dementia, stroke, or brain injury or diagnosis of a major mental illness such as major depression, schizophrenia, or bipolar disorder; active alcohol or substance abuse.
Data sourced from ClinicalTrials.gov (NCT02023944). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.